Structural and Functional Dynamics of Nontuberculous Mycobacterium Proteins
Insights into Pathogenic Mechanisms
- 1st Edition - August 1, 2026
- Latest edition
- Authors: Parissa Farnia, Ali Akbar Velayati, Poopak Farnia, Jalaledin Ghanavi
- Language: English
Structural and Functional Dynamics of Nontuberculous Mycobacterium Proteins: Insights into Pathogenic Mechanisms explores the structural and functional dynamics of nontub… Read more
- Examines the structures of key proteins from nontuberculous mycobacteria, highlighting functional domains and binding sites essential for understanding how these bacteria cause disease
- Analyzes interactions between nontuberculous mycobacteria and host cells to reveal the mechanisms of immune evasion and infection
- Investigates potential therapeutic targets to help develop treatments to combat infections caused by nontuberculous mycobacteria
- Addresses the growing challenge of antibiotic resistance by comparing mechanisms across slow and rapid-growing mycobacteria
2. Key Structural Features of NTM Proteins
3. Pathogenic Mechanisms of Nontuberculous Mycobacteria
4. Virulence Factors of Nontuberculous Mycobacterium
5. Antibiotic Resistance in Nontuberculous Mycobacteria
6. Future Directions and Emerging Research in Nontuberculous Mycobacteria
7. Perspectives on the Future of Treatment and Prevention Strategies
- Edition: 1
- Latest edition
- Published: August 1, 2026
- Language: English
PF
Parissa Farnia
AV
Ali Akbar Velayati
PF
Poopak Farnia
JG
Jalaledin Ghanavi
Jalaledin Ghanavi, MD, is surgeon, an Associate Professor, and the Head of the Department of Tissue Engineering and Experimental Medicine in the Mycobacteriology Research Center at the National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences in Tehran, Iran. He received the MD degree from the Isfahan University of Medical Science and has medical expertise in general medicine and general surgery. His ongoing research interests include tissue engineering, nanoarchitectonics, biomedicine, and nanomedicine, and he holds five U.S patents.